<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37338743</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Pattern of systemic lupus erythematosus in NIGERIA: a multicentre descriptive hospital-based study.</ArticleTitle><Pagination><StartPage>2787</StartPage><EndPage>2797</EndPage><MedlinePgn>2787-2797</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06672-y</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease with manifestations ranging from mild to life-threatening organ dysfunction. There is wide variability in the reported incidence and prevalence rate globally, particularly in low and middle-income countries. Nigeria had very few isolated reports of SLE from private and public hospitals Therefore, we conducted this large multi-center descriptive study to determine the sociodemographic, clinical profile, laboratory patterns, and treatment among Nigerian lupus patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective hospital-based study of all SLE patients seen over 4&#xa0;years (January 2017 to December 2020) was conducted at 20 rheumatology clinics spread across the 6 geopolitical zones of Nigeria. All patients 18&#xa0;years and above satisfying the American College of Rheumatology (ACR) 1997 and/or the Systemic Lupus International Collaboration Clinics (SLICC) 2012 classification criteria for SLE were enrolled. Patients with other Rheumatic and Musculoskeletal Diseases (RMDs) not in keeping with SLE and Patients with incomplete data were excluded. Data was analysed using SPSS version 23.0 software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 896 patients with SLE were included in the final analysis with a mean age&#x2009;&#xb1;&#x2009;SD of 34.47&#x2009;&#xb1;&#x2009;11 and a female to male ratio of 8.1:1. Synovitis was reported by 61.6% of patients, while 51%, 19.9% and11.4% patients reported acute, sub-acute and chronic lupus rashes respectively. ANA was positive in 98.0% with titers ranging from 1:80 to 1:64,000.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">SLE is not rare in Nigeria. Most patients were female in their 3rd to 4th decades of life. There is a delayed presentation to a rheumatology facility. Arthritis and mucocutaneous manifestations were the most frequent presentation. Key Points &#x2022;This study presents the first national data on SLE in Nigeria &#x2022;This study showed that SLE is not rare in Nigeria in contrast to previous reports &#x2022;There appear to be ethnic disparity in the frequency of lupus among Nigerians &#x2022;Nigerians with lupus have very high titer of ANA.</AbstractText><CopyrightInformation>&#xa9; 2023. International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Osaze</LastName><ForeName>Ojo</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Kubwa General Hospital Abuja, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olaosebikan</LastName><ForeName>Hakeem Babatunde</ForeName><Initials>HB</Initials><Identifier Source="ORCID">0000-0003-4004-0093</Identifier><AffiliationInfo><Affiliation>Lagos State University College of Medicine/ Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yerima</LastName><ForeName>Abubakar</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6694-507X</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Maiduguri, Maiduguri, Borno State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uhunmwangho</LastName><ForeName>Courage Ukponmwan</ForeName><Initials>CU</Initials><Identifier Source="ORCID">0000-0003-4776-8749</Identifier><AffiliationInfo><Affiliation>Department of Medicine, College of Health Sciences, University of Jos, Jos, Nigeria. uhunmwanghoc@unijos.edu.ng.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ima-Edomwonyi</LastName><ForeName>Uyiekpen Emmanuel</ForeName><Initials>UE</Initials><Identifier Source="ORCID">0000-0001-7651-5025</Identifier><AffiliationInfo><Affiliation>Lagos University Teaching Hospital, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oguntona</LastName><ForeName>Akintayo Segun</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0003-4682-3662</Identifier><AffiliationInfo><Affiliation>Olabisi Onabanjo University, Sagamu, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chibuzo</LastName><ForeName>Okwara Celestine</ForeName><Initials>OC</Initials><Identifier Source="ORCID">0000-0002-7727-5657</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Nigeria, Enugu, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dedeke</LastName><ForeName>Ibukunoluwa Ayoade</ForeName><Initials>IA</Initials><Identifier Source="ORCID">0000-0002-6494-0654</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University College Hospital, Ibadan, Oyo State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Na'isa</LastName><ForeName>Musa Bello Kofar</ForeName><Initials>MBK</Initials><Identifier Source="ORCID">0000-0003-4324-9757</Identifier><AffiliationInfo><Affiliation>Aminu Kano Teaching Hospital, Kano, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nwankwo</LastName><ForeName>Henry Madu</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0002-5679-7093</Identifier><AffiliationInfo><Affiliation>College of Medicine, Nnamdi Azikiwe University Awka, Awka, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agun-Ebreme</LastName><ForeName>Mary</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6960-4580</Identifier><AffiliationInfo><Affiliation>University of Benin Teaching Hospital, Benin, Edo State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>John-Maduagwu</LastName><ForeName>Obiageli Jane</ForeName><Initials>OJ</Initials><Identifier Source="ORCID">0000-0003-3358-2011</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Alex Ekwueme Federal University Teaching Hospital Abakaliki, Abakaliki, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ekeigwe</LastName><ForeName>Ngozi Lina</ForeName><Initials>NL</Initials><Identifier Source="ORCID">0000-0001-5132-7941</Identifier><AffiliationInfo><Affiliation>Federal Medical Center Owerri, Owerri, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adenitan</LastName><ForeName>Ajibade</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2801-7694</Identifier><AffiliationInfo><Affiliation>Federal Medical Centre, Gombe, Gombe State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emorinken</LastName><ForeName>Airenakho</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3306-572X</Identifier><AffiliationInfo><Affiliation>Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Odunlami</LastName><ForeName>Gbenga Joshua</ForeName><Initials>GJ</Initials><Identifier Source="ORCID">0000-0001-5995-5678</Identifier><AffiliationInfo><Affiliation>Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uchechukwu</LastName><ForeName>Tralagba</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Augie</LastName><ForeName>Abdullahi Ibrahim</ForeName><Initials>AI</Initials><Identifier Source="ORCID">0000-0002-8021-9189</Identifier><AffiliationInfo><Affiliation>Usmanu Danfodiyo University Teaching Hospital Sokoto, Sokoto, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdul'Aziz</LastName><ForeName>Umar</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0003-3199-7504</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Ahmadu Bello University Teaching Hospital Zaria, Zaria, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adelowo</LastName><ForeName>Olufemi</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-5815-0170</Identifier><AffiliationInfo><Affiliation>Lagos State University College of Medicine/ Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001168" MajorTopicYN="Y">Arthritis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lupus</Keyword><Keyword MajorTopicYN="N">Nigeria</Keyword><Keyword MajorTopicYN="N">Pattern</Keyword><Keyword MajorTopicYN="N">Registry</Keyword><Keyword MajorTopicYN="N">SLE</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>20</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>20</Day><Hour>11</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37338743</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06672-y</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06672-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Lupus Federation (2020) World Lupus Federation Global Survey 2020- Finds lupus greatly impacts physical function and quality of life. https://worldlupusfederation.org/2020/05/07/world-lupus-federation-global-survey-2020-topline-summary/ Accessed 21 February 2022</Citation></Reference><Reference><Citation>Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, Svenungsson E, Peterson J, Clarke AE, Ramsey-Goldman R (2021) Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 17:515&#x2013;532. https://doi.org/10.1038/s41584-021-00668-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00668-1</ArticleId><ArticleId IdType="pubmed">34345022</ArticleId><ArticleId IdType="pmc">8982275</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatoye F, Gebrye T, Mbada C (2022) Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle-income countries: a systematic review and meta-analysis. Rheumatol Int. https://doi.org/10.1007/s00296-022-05183-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05183-4</ArticleId><ArticleId IdType="pubmed">36006459</ArticleId><ArticleId IdType="pmc">9548466</ArticleId></ArticleIdList></Reference><Reference><Citation>Essouma M, Nkeck JR, Endomba FT, Bigna JJ, Singwe-Ngandeu M, Hachulla E (2020) Systemic lupus erythematosus in Native sub-Saharan Africans: A systematic review and meta-analysis. J Autoimmun. https://doi.org/10.1016/j.jaut.2019.102348</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102348</ArticleId><ArticleId IdType="pubmed">31668352</ArticleId></ArticleIdList></Reference><Reference><Citation>Adelowo O, Mody GM, Tikly M, Oyoo O, Slimani S (2021) Rheumatic diseases in Africa. Nat Rev Rheumatol 17:363&#x2013;374. https://doi.org/10.1038/s41584-021-00603-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00603-4</ArticleId><ArticleId IdType="pubmed">33850309</ArticleId><ArticleId IdType="pmc">8043097</ArticleId></ArticleIdList></Reference><Reference><Citation>Adelowo OO, Ojo O, Oduenyi I, Okwara CC (2010) Rheumatoid arthritis among Nigerians: the first 200 patients from a rheumatology clinic. Clin Rheumatol 29:593&#x2013;597</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-009-1355-0</ArticleId><ArticleId IdType="pubmed">20094746</ArticleId></ArticleIdList></Reference><Reference><Citation>Emorinken A, Dic-Ijiewere MO, Erameh CO, Ugheoke AJ, Agbadaola OR, Agbebaku FO (2021) Clinical and laboratory profile of systemic lupus erythematosus patients at a rural tertiary centre in South-South Nigeria: experience from a new rheumatology clinic. Reumatologia 59:402&#x2013;410. https://doi.org/10.5114/reum.2021.111714</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/reum.2021.111714</ArticleId><ArticleId IdType="pubmed">35079185</ArticleId><ArticleId IdType="pmc">8768036</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. https://doi.org/10.1002/art.1780400928</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarc&#xf3;n GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677&#x2013;2686. https://doi.org/10.1002/art.34473</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId><ArticleId IdType="pmc">3409311</ArticleId></ArticleIdList></Reference><Reference><Citation>Markowitz GS, D&#x2019;Agati VD (2007) The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years. Kidney Int 71:491&#x2013;495. https://doi.org/10.1038/sj.ki.5002118</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002118</ArticleId><ArticleId IdType="pubmed">17264872</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanfir MS, Houman MH, Cherif E, Hamzaoui A, Souissi S, Ben Ghorbel I et al (2013) TULUP (TUnisian LUPus): a multicentric study of systemic lupus erythematosus in Tunisia. Int J Rheum Dis 16:539&#x2013;546</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.12152</ArticleId><ArticleId IdType="pubmed">24164841</ArticleId></ArticleIdList></Reference><Reference><Citation>El Hadidi KT, Medhat BM, Abdel Baki NM, Abdel Kafy H, Abdelrahaman W, Yousri AY et al (2018) Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center. Lupus 27:1030&#x2013;1038</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203317751856</ArticleId><ArticleId IdType="pubmed">29431056</ArticleId></ArticleIdList></Reference><Reference><Citation>Budhoo A, Mody GM, Dubula T, Patel N, Mody PG (2017) Comparison of ethnicity, gender, age of onset and outcome in South Africans with systemic lupus erythematosus. Lupus 26:438&#x2013;446</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316676380</ArticleId><ArticleId IdType="pubmed">27837197</ArticleId></ArticleIdList></Reference><Reference><Citation>Adelowo OO, Ojo O, Oduenyi I (2012) Autoantibodies in Nigerian lupus patients. Afr J Med Sci 41:177&#x2013;181</Citation></Reference><Reference><Citation>Symmons DP (1995) Frequency of lupus in people of African origin. Lupus 4:176&#x2013;178</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339500400303</ArticleId><ArticleId IdType="pubmed">7655486</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae SC, Fraser P, Liang MH (1998) The epidemiology of systemic lupus erythematosus in populations of African ancestry: a critical review of the &#x201c;prevalence gradient hypothesis.&#x201d; Arthritis Rheum 41:2091&#x2013;2099</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(199812)41:12&lt;2091::AID-ART2&gt;3.0.CO;2-D</ArticleId><ArticleId IdType="pubmed">9870865</ArticleId></ArticleIdList></Reference><Reference><Citation>Adwan M (2018) Clinical and Serologic Characteristics of Systemic Lupus Erythematosus in the Arab World: A Pooled Analysis of 3,273 Patients. Arch Rheumatol 33:455&#x2013;463</Citation><ArticleIdList><ArticleId IdType="doi">10.5606/ArchRheumatol.2018.6832</ArticleId><ArticleId IdType="pubmed">30874242</ArticleId><ArticleId IdType="pmc">6409177</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Wang Y, Zhao J, Wang Q, Wang Z, Tian X, Zeng X (2021) Chinese SLE Treatment and Research Group (CSTAR) Registry 2009&#x2013;2019: major clinical characteristics of Chinese patients with systemic lupus erythematosus. Rheumatol Immunol Res 2:43&#x2013;47</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/rir-2021-0001</ArticleId><ArticleId IdType="pubmed">36467897</ArticleId><ArticleId IdType="pmc">9524770</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al (1993) Systemic lupus erythematosus:clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European working party on systemic lupus erythematosus. Medicine (Baltimore) 72:113&#x2013;124</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005792-199303000-00005</ArticleId><ArticleId IdType="pubmed">8479324</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR et al (2004) The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among &#x201c;Hispanics.&#x201d; Medicine (Baltimore) 83:1&#x2013;17. https://doi.org/10.1097/01.md.0000104742.42401.e2</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.md.0000104742.42401.e2</ArticleId><ArticleId IdType="pubmed">14747764</ArticleId></ArticleIdList></Reference><Reference><Citation>Maningding E, Dall&#x2019;Era M, Trupin L, Murphy LB, Yazdany J (2020) Racial and ethnic differences in the prevalence and time to onset of manifestations of systemic lupus erythematosus: the California lupus surveillance project. Arthritis Care Res (Hoboken) 72:622&#x2013;629</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.23887</ArticleId><ArticleId IdType="pubmed">31115180</ArticleId></ArticleIdList></Reference><Reference><Citation>Gergianaki I, Garantziotis P, Adamichou C, Saridakis I, Spyrou G, Sidiropoulos P, Bertsias G (2021) High comorbidity burden in patients with sle: data from the community-based lupus registry of crete. J Clin Med 10:998. https://doi.org/10.3390/jcm10050998</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10050998</ArticleId><ArticleId IdType="pubmed">33801229</ArticleId><ArticleId IdType="pmc">7957898</ArticleId></ArticleIdList></Reference><Reference><Citation>Pryor KP, Barbhaiya M, Costenbader KH, Feldman CH (2020) Disparities in lupus and lupus nephritis care and outcomes among us medicaid beneficiaries. Rheum Dis Clin North Am 47:41&#x2013;53. https://doi.org/10.1016/j.rdc.2020.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2020.09.004</ArticleId><ArticleId IdType="pubmed">34042053</ArticleId><ArticleId IdType="pmc">8171807</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbagir S, Elshafie AI, Elagib EM, Mohammed NA, Aledrissy MIE, Sohrabian A et al (2020) Sudanese and Swedish patients with systemic lupus erythematosus: immunological and clinical comparisons. Rheumatology (Oxford) 59:968&#x2013;978</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kez323</ArticleId><ArticleId IdType="pubmed">31411331</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Zheng Y, Chen L et al (2022) High titers of antinuclear antibody and the presence of multiple autoantibodies are highly suggestive of systemic lupus erythematosus. Sci Rep 12:1687. https://doi.org/10.1038/s41598-022-05807-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-05807-6</ArticleId><ArticleId IdType="pubmed">35105907</ArticleId><ArticleId IdType="pmc">8807846</ArticleId></ArticleIdList></Reference><Reference><Citation>Han BK, Rathwell E, Ng B, Wener M (2018). Evaluation of Erythrocyte Sedimentation Rate As a Marker&#xa0;of Disease Activity in Patients with Systemic Lupus Erythematosus [abstract].&#xa0;Arthritis Rheumatol.&#xa0;70 (suppl 10). https://acrabstracts.org/abstract/evaluation-of-erythrocyte-sedimentation-rate-as-a-marker-of-disease-activity-in-patients-with-systemic-lupus-erythematosus/ . Accessed 21 February 2022</Citation></Reference><Reference><Citation>Akintayo RO, Akpabio AA, Kalla AA, Dey D, Migowa AN, Olaosebikan H et al (2021) The impact of COVID-19 on rheumatology practice across Africa. Rheumatology (Oxford) 60:392&#x2013;398. https://doi.org/10.1093/rheumatology/keaa600</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa600</ArticleId><ArticleId IdType="pubmed">33020845</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah R, Dey D, Pietzonka T, Obeng P, Ashiru B, Schiestl M, Cavey A, Nkansah E, Radiere G, Spector J, Scott C (2020) Determinants of use of biotherapeutics in sub-Saharan Africa. Trends Pharmacol Sci 42:75&#x2013;84. https://doi.org/10.1016/j.tips.2020.11.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2020.11.012</ArticleId><ArticleId IdType="pubmed">33358177</ArticleId></ArticleIdList></Reference><Reference><Citation>Adelowo OO, Olisa O, Asekhame OT, Ojo O (2021) Biotherapies in medical practice: a review and the Nigerian experience. West Afr J Med 38:486&#x2013;493</Citation><ArticleIdList><ArticleId IdType="pubmed">34051722</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>